Literature DB >> 2840670

Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice.

O Dill1, F Kievits, S Koch, P Ivanyi, G J Hämmerling.   

Abstract

The human major histocompatibility complex encodes three classical class I antigens, HLA-A, -B, and -C. Of these HLA-A and -B act as strong transplantation antigens and as restriction molecules for recognition of foreign antigen by cytotoxic T lymphocytes. In contrast, little is known about HLA-C and it is not clear whether HLA-C has the same functional properties as HLA-A and -B. Transgenic C57BL/6 mice expressing the HLA-Cw3 gene were established. Functional studies demonstrated that transgenic skin was rapidly rejected by normal C57BL/6 mice and that cytotoxic T lymphocytes generated by immunization of the Cw3 transgenic mice with influenza and Sendai virus were restricted by the Cw3 molecule. These data suggest that HLA-Cw3 has immunological functions comparable to those of HLA-A and -B.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840670      PMCID: PMC281820          DOI: 10.1073/pnas.85.15.5664

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects.

Authors:  D Güssow; R S Rein; I Meijer; W de Hoog; G H Seemann; F M Hochstenbach; H L Ploegh
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

Review 4.  Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice.

Authors:  H Lemke; G J Hämmerling; U Hämmerling
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

5.  [The sub-loci of the HL-A system. The main system of histocompatibility in man].

Authors:  J Dausset; J Colombani; L Legrand; N Feingold
Journal:  Presse Med       Date:  1969-05-10       Impact factor: 1.228

6.  Influence of HLA-A, B, C, D, and DR matching in renal transplantation.

Authors:  D Albrechtsen; T Moen; A Flatmark; S Halvorsen; A Jakobsen; J Jervell; B G Solheim; E Thorsby
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

7.  Human cell-mediated cytotoxicity against modified target cells is restricted by HLA.

Authors:  E Dickmeiss; B Soeberg; A Svejgaard
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

8.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells.

Authors:  A J McMichael; A Ting; H J Zweerink; B A Askonas
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

9.  Cell mediated lympholysis in man. The impact of HLA-C antigens.

Authors:  N Grunnet; T Kristensen; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1976-05

10.  Molecular structure of human histocompatibility antigens: the HLA-C series.

Authors:  D Snary; C J Barnstable; W F Bodmer; M J Crumpton
Journal:  Eur J Immunol       Date:  1977-08       Impact factor: 5.532

View more
  27 in total

1.  Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Authors:  A Cambiaggi; C Verthuy; P Naquet; F Romagné; P Ferrier; R Biassoni; A Moretta; L Moretta; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

Authors:  Christoph Esslinger; Laurence Chapatte; Daniela Finke; Isabelle Miconnet; Philippe Guillaume; Frédéric Lévy; H Robson MacDonald
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Promoter region of HLA-C genes: regulatory elements common to and different from those of HLA-A and HLA-B genes.

Authors:  D Tibensky; T L Delovitch
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo.

Authors:  Caroline Sola; Pascale André; Céline Lemmers; Nicolas Fuseri; Cécile Bonnafous; Mathieu Bléry; Nicolai R Wagtmann; François Romagné; Eric Vivier; Sophie Ugolini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

Review 5.  HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?

Authors:  Marie-Eve Blais; Tao Dong; Sarah Rowland-Jones
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

Review 6.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

7.  HLA-C "blank" alleles express class I gene products. Biochemical analysis of four different HLA-C "blank" polypeptides.

Authors:  A Hajek-Rosenmayr; L Jungl; M Stammler; M Kirnbauer
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

8.  Mouse cytotoxic T cells can recognize HLA-B27 antigen without H-2 restriction.

Authors:  A Samaan; D Gillet; M Chopin; L Degos; M Pla
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

9.  Membrane expression of HLA-Cw4 free chains in activated T cells of transgenic mice.

Authors:  A Aiuti; P Forte; L Simeoni; M Lino; L Pozzi; A Fattorossi; P Giacomini; E Ginelli; A Beretta; A Siccardi
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice.

Authors:  S Pedrinaci; J Hanson; C David
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.